(Philadelphia,
PA) - Christina S. Chu, MD, has joined the Department
of Obstetrics and Gynecology at the University of Pennsylvania
School of Medicine as an Assistant Professor, effective
immediately.
Chu is a junior fellow in the American College of Obstetricians
and Gynecologists and a candidate member in the Society
of Gynecologic Oncologists. Her primary research interests
rest on immunotherapies and novel chemotherapeutics
for gynecologic malignancies. She is currently the Physician
Champion for Penn's Division of Gynecologic Oncology,
EpicCare Implementation Committee, Department of Obstetrics
of Gynecology. As a part of her teaching and clinical
responsibilities at Penn, Chu supervises students, residents,
and fellows in the daily management of both inpatients
and outpatients; teaches medical student lectures on
gynecologic malignancies and lab sessions on tumor progression;
and is a weekly participant at the Gynecologic Oncology
Pathology and Treatment Planning Conference.
She earned her medical degree from the University of
Pennsylvania School of Medicine in 1995 and completed
her residency in Obstetrics and Gyencology and her fellowship
in Gynecologic Oncology at the Hospital of the University
of Pennsylvania in 1999 and 2002, respectively. She
is a recipient of the 2001 AACR-Glaxo SmithKline Scholar
in Training Award and is board eligible for certification
by The American Board of Obstetrics and Gynecology.
Chu is a member of the Editorial Board of the Abramson
Cancer Center of the University of Pennsylvania's web
site OncoLink; the American Medical Association; and
an associate member of the American Association for
Cancer Research.
# # #
.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.